Chen Yan, Zhu Jiechang, Ma Zhicheng, Dai Xiangchen, Fan Hailun, Feng Zhou, Zhang Yiwei, Luo Yudong
Department of General Surgery, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China.
Department of General Surgery, Tianjin First Center Hospital, Tianjin 300192, P.R. China.
Exp Ther Med. 2015 Jun;9(6):2359-2363. doi: 10.3892/etm.2015.2413. Epub 2015 Apr 7.
Acute mesenteric ischemia is a condition with a high mortality rate. In the present study, a novel hybrid technique for the treatment of acute mesenteric ischemia was investigated. The retrospective study population included six patients, of which five were male and one was female, with a mean age of 69 years (age range, 59-73 years). The hybrid technique involved isolating the superior mesenteric artery (SMA) for cannulation and subsequently performing a fluoroscopically-assisted embolectomy, retrograde balloon angioplasty and stenting. Intra-arterial, catheter-directed thrombolysis was performed if required. Bowels showing evident necrosis were resected, while ischemic bowels with the potential for recovery were left for 48 h before being re-examined during the second-look surgery. Retrograde open mesenteric stenting (ROMS) was successfully performed on two patients without bowel resection. Four patients were successfully treated by intra-arterial catheter-directed thrombolysis following recanalization of the SMA, and the ischemic bowels had exhibited a full recovery by the second-look operation. Three patients underwent a massive bowel resection, but did not develop short bowel syndrome. Two patients developed acute renal failure, one of which recovered after 10 days of dialysis, while the other patient succumbed to acute renal failure. In the five surviving patients, the SMA remained patent for the duration of the follow-up period. Therefore, ROMS was shown to be a viable alternative procedure for emergent SMA revascularization. In addition, intra-arterial catheter-directed thrombolysis following recanalization of the SMA was demonstrated as an alternative technique for inhibiting necrosis in bowels with acute mesenteric ischemia.
急性肠系膜缺血是一种死亡率很高的疾病。在本研究中,对一种治疗急性肠系膜缺血的新型杂交技术进行了研究。回顾性研究人群包括6例患者,其中5例为男性,1例为女性,平均年龄69岁(年龄范围59 - 73岁)。该杂交技术包括分离肠系膜上动脉(SMA)以进行插管,随后进行荧光透视辅助取栓术、逆行球囊血管成形术和支架置入术。如有需要,进行动脉内导管定向溶栓。对显示明显坏死的肠段进行切除,而对有恢复可能的缺血肠段则保留48小时,然后在二次探查手术中重新检查。两名患者成功进行了逆行开放肠系膜支架置入术(ROMS),未进行肠切除。4例患者在SMA再通后通过动脉内导管定向溶栓成功治疗,缺血肠段在二次探查手术时已完全恢复。3例患者接受了大范围肠切除,但未发生短肠综合征。2例患者发生急性肾衰竭,其中1例在透析10天后恢复,另1例死于急性肾衰竭。在5例存活患者中,随访期间SMA保持通畅。因此,ROMS被证明是紧急SMA血管重建的一种可行替代方法。此外,SMA再通后动脉内导管定向溶栓被证明是抑制急性肠系膜缺血肠段坏死的一种替代技术。